Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

The new 2017 ACC/AHA guideline for classification of hypertension: changes in prevalence of hypertension among adults in Bangladesh

Abstract

We analyzed the Bangladesh Demographic and Health Survey 2011 data to examine absolute differences in hypertension prevalence according to the hypertension definition of the “2017 American College of Cardiology/American Heart Association (2017 ACC/AHA) Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults” and “Seventh Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC7)” 2003 guidelines. Among 7839 participants ≥35 years, the JNC7 and 2017 ACC/AHA classified 25.7% (95% confidence interval (CI): 24.5–27.0%) and 48.0% (95% CI: 46.4–49.7%) people hypertensive, respectively. The JNC7 prevalence was 19.4% (95% CI: 18.0-21.0%) among males and 31.9% (95% CI: 30.1-33.6%) among females. The prevalence was 41.4% (95% CI: 39.4-43.5%) among males and 54.5% (95% CI: 52.4-56.4%) among females as per the 2017 ACC/AHA guideline. From JNC7 to 2017 ACC/AHA, the overall difference in prevalence was 22.3% (95% CI: 19.8–24.8%). Males and females had similar differences, 22.0% (95% CI: 18.3–25.7%) and 22.6% (95% CI: 19.4–26.0%), respectively. As per the 2017 ACC/AHA guideline, >50% prevalence was observed among people with body mass index ≥25 kg/m2, college-level education, co-morbid diabetes, richest wealth quintile, females, age ≥55 years, urban residence, or living in Khulna, Rangpur or Dhaka divisions; the absolute difference was >20% in most categories. We found a substantial increase in the prevalence of hypertension due to change in blood pressure thresholds as per the 2017 ACC/AHA guideline. We recommend conducting more comprehensive population-based studies to estimate the recent burden of hypertension in Bangladesh. Future studies should estimate similar prevalence in other countries.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389:37–55.

  2. Basu S, Millett C. Social epidemiology of hypertension in middle-income countries: determinants of prevalence, diagnosis, treatment, and control in the WHO SAGE study. Hypertension. 2013;62:18–26.

    Article  CAS  Google Scholar 

  3. Lloyd-Sherlock P, Beard J, Minicuci N, Ebrahim S, Chatterji S. Hypertension among older adults in low- and middle-income countries: prevalence, awareness and control. Int J Epidemiol. 2014;43:116–28.

    Article  Google Scholar 

  4. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014;2:634–47.

    Article  Google Scholar 

  5. National Institute of Population Research and Training (NIPORT), Mitra and Associates, and ICF International. Bangladesh Demographic and Health Survey 2011. 2013.

  6. World Health Organization. Non-communicable disease risk factor survey Bangladesh 2010. Dhaka: WHO; 2011.

    Google Scholar 

  7. National Institute of Population Research and Training (NIPORT), Mitra and Associates, ICF International. Bangladesh Demographic and Health Survey 2014. 2016.

  8. Chalmers J, et al. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Committee. J Hypertens. 1999;17:151–83.

    Google Scholar 

  9. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–72.

    Article  CAS  Google Scholar 

  10. Whelton PK, Carey RM, Aronow WS, Casey DEJ, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017:HYP.0000000000000065.

  11. Lewington S,Clarke R,Qizilbash N,Peto R,Collins R,Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.

    Article  Google Scholar 

  12. Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet. 2014;383:1899–911.

    Article  Google Scholar 

  13. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001;358:1682–6.

    Article  CAS  Google Scholar 

  14. Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright JT,Jr, et al. Potential U.S. Population Impact of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline. Circulation 2017:137. https://doi.org/10.1161/CIRCULATIONAHA.117.032582.

    Article  Google Scholar 

  15. Bangladesh Bureau of Statistics. Bangladesh Population and Housing Census. 2011.

  16. Jolliffe IT, Cadima J. Principal component analysis: a review and recent developments. Philos Trans A Math Phys Eng Sci. 2016;374:20150202.

    Article  Google Scholar 

  17. Filmer D, Pritchett LH. Estimating wealth effects without expenditure data--or tears: an application to educational enrollments in states of India. Demography. 2001;38:115–32.

    CAS  PubMed  Google Scholar 

  18. Stata Corporation. Stata Statistical Software. Release 14.0. College Station, TX: StataCorp LP: Stata Corporation; 2015.

    Google Scholar 

  19. Khera R, Lu Y, Saxena A, Nasir K, Krumholz HM. The impact of 2017 ACC/AHA Guidelines on the prevalence of hypertension and eligibility for anti-hypertensive therapy in the United States and China. bioRxiv. 2017:218859. https://doi.org/10.1101/218859.

  20. Mahajan R. Joint National Committee 8 report: How it differ from JNC 7. Int J Appl Basic Med Res. 2014;4:61–62.

    Article  Google Scholar 

  21. Seedat Y. Hypertension in developing nations in sub-Saharan Africa. J Hum Hypertens. 2000;14:739.

    Article  CAS  Google Scholar 

  22. Fuentes R, Ilmaniemi N, Laurikainen E, Tuomilehto J, Nissinen A. Hypertension in developing economies: a review of population‐based studies carried out from 1980 to 1998. J Hypertens. 2000;18:521–9.

    Article  CAS  Google Scholar 

  23. Chockalingam A, Campbell NR, Fodor JG. Worldwide epidemic of hypertension. Can J Cardiol. 2006;22:553–5.

    Article  Google Scholar 

  24. Deuboue Tchialeu RI, Yaya S, Labonte R. Health systems readiness to manage the hypertension epidemic in primary health care facilities in the Western Cape, South Africa: a study protocol. JMIR Res Protoc. 2016;5:e35.

    Article  Google Scholar 

  25. Campbell NR, Niebylski ML, World Hypertension League Executive. Prevention and control of hypertension: developing a global agenda. Curr Opin Cardiol. 2014;29:324–30.

    Article  Google Scholar 

  26. Biswas T, Pervin S, Tanim MIA, Niessen L, Islam A. Bangladesh policy on prevention and control of non-communicable diseases: a policy analysis. BMC Public Health. 2017;17:582-017-4494-2.

  27. World Health Organization (WHO). About 9 Voluntary Targets. 2017. http://www.who.int/nmh/ncd-tools/definition-targets/en/. Accessed 26 Feb 2017.

  28. Marquez-Contreras E, de la Figuera Von Wichmann M, Aguilera de la Fuente MT, Garrido Garcia J. The influence of correct blood pressure measurement on the diagnostic decisions in hypertensive patients. MEDIDA study. Med Clin. 2008;131:321–5.

    Article  Google Scholar 

  29. Harshfield E, Chowdhury R, Harhay MN, Bergquist H, Harhay MO. Association of hypertension and hyperglycaemia with socioeconomic contexts in resource-poor settings: the Bangladesh Demographic and Health Survey. Int J Epidemiol. 2015;44:1625–36.

    Article  Google Scholar 

Download references

Acknowledgements

We thank the ICF International, Rockville, Maryland, USA for giving us the permission to use the data for this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gulam Muhammed Al Kibria.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kibria, G.A., Swasey, K., Choudhury, A. et al. The new 2017 ACC/AHA guideline for classification of hypertension: changes in prevalence of hypertension among adults in Bangladesh. J Hum Hypertens 32, 608–616 (2018). https://doi.org/10.1038/s41371-018-0080-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-018-0080-z

This article is cited by

Search

Quick links